Fixed drug eruption from ticlopidine, with positive lesional patch test

Contact Dermatitis

Volumn 44, Issue 1, 2001, Pages 40-41

  Martin Garcia C ^a   Carmena, R ^a   Garcia R ^a   Berges, P ^a   Camacho, E ^a   Cotter, M P ^a   De La Hoz, B ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Adverse drug reactions; Antiplatelet drugs; Fixed drug eruption; Lack of cross sensitivity; Oral provocation; Positive lesional patch test; Ticlopidine

Indexed keywords

CLOPIDOGREL; TICLOPIDINE;

ADULT; ARTICLE; CASE REPORT; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; DISEASE COURSE; DRUG ERUPTION; FEMALE; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; PATCH TEST; PROVOCATION TEST; SKIN BIOPSY; TREATMENT OUTCOME;

CROSS REACTIONS; DERMATITIS, ALLERGIC CONTACT; DRUG ERUPTIONS; FEMALE; HUMANS; MIDDLE AGED; PATCH TESTS; PLATELET AGGREGATION INHIBITORS; SKIN; TICLOPIDINE;

EID: 0035197778     PISSN: 01051873     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0536.2001.440107-15.x     Document Type: Article

References (9)

1. Vasomodulatory action of colpidogrel and ticlopidine
2. Ticlopidine. An updated review of its pharmacology and therapeutic use in platelet-dependent disorders
3. Thrombotic thrombocytopenic purpura: A rare but potentially life-threatening complication following ticlopidine administration
4. Toxic erythroderma due to ticlopidine
5. Tetracycline-induced fixed drug eruptions: Influence of dose and structure of tetracyclines
6. Fixed drug eruptions
7. Fixed drug eruptions
8. Fixed drug eruption